Durie B G, Salmon S
Bull Cancer. 1980;67(4):450-7.
In the past decade a number of single agents and combinations of drugs have been introduced in the treatment of patients with multiple myeloma. In this paper special attention is directed to the analysis of prognostic factors and the identification of subgroups at the time of diagnosis, stable plateau phase following induction and at the time of relapse. A comprehensive approach to the treatment of patients with multiple myeloma is presented.
在过去十年中，多种单药及联合用药已被用于多发性骨髓瘤患者的治疗。本文特别关注对预后因素的分析以及在诊断时、诱导治疗后的稳定平台期和复发时对亚组的识别。本文还介绍了一种治疗多发性骨髓瘤患者的综合方法。
